Who makes [14C]-GSK3640254 powder?

[14C]-GSK3640254 powder is developed by ViiV Healthcare.

What development phase is [14C]-GSK3640254 powder in?

[14C]-GSK3640254 powder is in Phase 1.

Last reviewed 2026-05-15 · How we verify

[14C]-GSK3640254 powder

ViiV Healthcare · Phase 1 active Small molecule

At a glance

Generic name	[14C]-GSK3640254 powder
Sponsor	ViiV Healthcare
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[14C]-GSK3640254 powder CI brief — competitive landscape report
[14C]-GSK3640254 powder updates RSS · CI watch RSS
ViiV Healthcare portfolio CI